Copyright
©The Author(s) 2015.
World J Cardiol. Jun 26, 2015; 7(6): 344-350
Published online Jun 26, 2015. doi: 10.4330/wjc.v7.i6.344
Published online Jun 26, 2015. doi: 10.4330/wjc.v7.i6.344
Predictor variable | Sensitivity | Specificity | PPV | NPV | AUROC (95%CI) |
Primary endpoint | |||||
Sustained VT during EPS | |||||
All study participants (n = 265) | 69.4% | 57.9% | 27.2% | 89.3% | 0.636 (0.563-0.709) |
Subgroup of study participants with LVEF < 35% (n = 106) | 66.7% | 48.1% | 30.5% | 80.9% | 0.574 (0.468-0.680) |
Subgroup of study participants with LVEF ≥ 35% (n = 159) | 72.7% | 63.5% | 24.2% | 93.5% | 0.681 (0.578-0.785) |
LVEF < 35% | 55.1% | 63.4% | 25.5% | 86.1% | 0.593 (0.515-0.670) |
Secondary endpoint | |||||
Sustained VT during EPS | |||||
All study participants (n = 265) | 66.7% | 55.6% | 17.6% | 92.1% | 0.611 (0.524-0.699) |
Subgroup of study participants with LVEF < 35% (n = 106) | 61.1% | 45.5% | 18.6% | 85.1% | 0.533 (0.406-0.660) |
Subgroup of study participants with LVEF ≥ 35% (n = 159) | 73.3% | 61.8% | 16.7% | 95.7% | 0.676 (0.553-0.798) |
LVEF < 35% | 54.5% | 62.1% | 17.0% | 90.6% | 0.583 (0.491-0.675) |
- Citation: Hilfiker G, Schoenenberger AW, Erne P, Kobza R. Utility of electrophysiological studies to predict arrhythmic events. World J Cardiol 2015; 7(6): 344-350
- URL: https://www.wjgnet.com/1949-8462/full/v7/i6/344.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i6.344